Non-Invasive, Real-Time Technology for Diagnosis of Cervical Tissue
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00250055|
Recruitment Status : Completed
First Posted : November 7, 2005
Last Update Posted : May 12, 2016
In general, to determine the sensitivity of light transport to tissue from morphological features of clinical significance.
Determine how specific structural features contribute to light scattering. Investigate light scattering differences in tumorigenic and nontumorigenic cells.
Develop and implement quantitative and sensitive methods for measuring morphological properties.
|Condition or disease||Intervention/treatment||Phase|
|Cervix Cancer||Procedure: Colposcopy, Spectroscopy, and Biopsy||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||100 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Official Title:||Non-Invasive, Real-time Technology for Diagnosis of Cervical Tissue|
|Study Start Date :||April 2004|
|Actual Primary Completion Date :||December 2007|
|Actual Study Completion Date :||January 2010|
- Procedure: Colposcopy, Spectroscopy, and Biopsy
During the colposcopy or LEEP (Loop Electrical Excision Procedure) procedure, or during pelvic exams before surgery after the doctor applies 3% acetic acid to the cervix, the doctor then positions the colposcope to take pictures of the patient's cervix. Digital pictures are taken of the patient's cervix under white light using a colposcopy imaging system. These pictures are annotated by the doctor during the appointment to mark the spectroscopy sites.
- The objective of this study is to determine whether non-invasive measurements of light transport through tissue can identify pre-cancerous and cancerous conditions. [ Time Frame: 6 years ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00250055
|United States, New Mexico|
|University of New Mexico|
|Albuquerque, New Mexico, United States, 87131|
|Principal Investigator:||Harriet Smith, MD||University of New Mexico|